ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,250, issued on Aug. 5, was assigned to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (Daejeon, South Korea).
"Tricyclic compound as IRAK4 inhibitor" was invented by Heeyeong Cho (Daejeon, South Korea), Hee-Jong Lim (Daejeon, South Korea), Woo Kyu Park (Daejeon, South Korea), Dae Young Jeong (Daejeon, South Korea), Hyeon Young Kim (Daejeon, South Korea), Sae-Bom Yoon (Daejeon, South Korea), Chong Ock Lee (Daejeon, South Korea), Heung Kyoung Lee (Daejeon, South Korea), Victor Sukbong Hong (Daejeon, South Korea) and Ji Hye Choi (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical compos...